Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Aliment Pharmacol Ther. 2015 Oct 1;42(0):1303–1314. doi: 10.1111/apt.13413

Figure 4.

Figure 4

Phosphorylation of smad 2/3: Duodenal biopsies from a representative OAE patient while on (A) or off (B) olmesartan medoxomil were stained with anti psmad 2/3 (brown). Panels C and D show the mean with standard deviation for nuclear (C) and intracellular (D) localization of unpaired duodenal biopsies from patients on or off olmesartan. There was no statistically significant difference with the nuclear localization between on and off olmesartan medoxomil (p=0.43); however, there was a statistically significant increase in the intracellular localization with the use of the drug, using unpaired t test with Welch’s correction (p<0.01).